Medical Properties Trust Inc (NYSE:MPW) Stock Price While Sentiment Increases

Sentiment for Medical Properties Trust Inc (NYSE:MPW)

Medical Properties Trust Inc (NYSE:MPW) institutional sentiment increased to 1.86 in Q1 2019. Its up 0.38, from 1.48 in 2018Q4. The ratio is positive, as 218 investment professionals increased or started new positions, while 117 cut down and sold equity positions in Medical Properties Trust Inc. The investment professionals in our partner’s database now possess: 305.39 million shares, up from 283.65 million shares in 2018Q4. Also, the number of investment professionals holding Medical Properties Trust Inc in their top 10 positions was flat from 4 to 4 for the same number . Sold All: 29 Reduced: 88 Increased: 145 New Position: 73.

Medical Properties Trust, Inc. operates as a real estate investment trust in the United States. The company has market cap of $8.23 billion. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. It has a 7.33 P/E ratio. The firm also provides mortgage loans to healthcare operators, as well as working capital and other term loans to its tenants/borrowers.

The stock increased 0.59% or $0.11 during the last trading session, reaching $18.73. About 3.76 million shares traded. Medical Properties Trust, Inc. (NYSE:MPW) has risen 23.94% since September 11, 2018 and is uptrending. It has outperformed by 23.94% the S&P500.

Analysts await Medical Properties Trust, Inc. (NYSE:MPW) to report earnings on November, 7. They expect $0.31 EPS, down 11.43 % or $0.04 from last year’s $0.35 per share. MPW’s profit will be $136.23M for 15.10 P/E if the $0.31 EPS becomes a reality. After $0.31 actual EPS reported by Medical Properties Trust, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

S. R. Schill & Associates holds 5.01% of its portfolio in Medical Properties Trust, Inc. for 448,764 shares. Cardinal Capital Management Llc Ct owns 6.78 million shares or 4.17% of their US portfolio. Moreover, Lvm Capital Management Ltd Mi has 2.79% invested in the company for 657,671 shares. The California-based Doheny Asset Management Ca has invested 2.49% in the stock. Polaris Greystone Financial Group Llc, a California-based fund reported 1.28 million shares.

Medical Properties Trust, Inc. (NYSE:MPW) Ratings Coverage

Ratings analysis reveals 60% of Medical Properties Trust’s analysts are positive. Out of 5 Wall Street analysts rating Medical Properties Trust, 3 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $16 while the high is $2100. The stock’s average target of $18.92 is 1.01% above today’s ($18.73) share price. MPW was included in 10 notes of analysts from March 20, 2019. The rating was maintained by Wells Fargo with “Hold” on Thursday, March 21. SunTrust maintained the stock with “Buy” rating in Tuesday, August 27 report. The firm earned “Hold” rating on Friday, March 29 by Deutsche Bank. The firm has “Overweight” rating by KeyBanc Capital Markets given on Wednesday, August 7.

More notable recent Medical Properties Trust, Inc. (NYSE:MPW) news were published by: Finance.Yahoo.com which released: “Do Directors Own Medical Properties Trust, Inc. (NYSE:MPW) Shares? – Yahoo Finance” on July 12, 2019, also Finance.Yahoo.com with their article: “3 Top Dividend Stocks With Yields Over 5% – Yahoo Finance” published on August 25, 2019, Seekingalpha.com published: “Medical Properties launches debt offering – Seeking Alpha” on July 17, 2019. More interesting news about Medical Properties Trust, Inc. (NYSE:MPW) were released by: Seekingalpha.com and their article: “Medical Properties buys majority stake in Swiss hospitals portfolio – Seeking Alpha” published on May 28, 2019 as well as Seekingalpha.com‘s news article titled: “Medical Properties Trust gains a bull (updated) – Seeking Alpha” with publication date: July 24, 2019.

Medical Properties Trust, Inc. (NYSE:MPW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.